Answer
There are no data on lutetium (177Lu) vipivotide tetraxetan in human milk or its effects on breast-fed infants or milk production; Pluvicto is not indicated for females, and its safety and efficacy in females have not been established.
Sources for this answer
- Pluvicto 1,000 MBq/mL solution for injection/infusionNovartis Pharmaceuticals UK Ltd · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 7Document updated
Sources checked